Items where Author is "Keller, U."

2016

Bounoure, L. and Gomes, F. and Stanga, Z. and Keller, U. and Meier, R. and Ballmer, P. and Fehr, R. and Mueller, B. and Genton, L. and Bertrand, P. C. and Norman, K. and Henzen, C. and Laviano, A. and Bischoff, S. and Schneider, S. M. and Kondrup, J. and Schuetz, P. and Members of the Working, Group. (2016) Detection and treatment of medical inpatients with or at-risk of malnutrition: Suggested procedures based on validated guidelines. Nutrition, 32 (7-8). pp. 790-798.

2013

Thomann, R. and Schutz, P. and Muller, B. and Thomke, S. and Schoenenberger, R. and Keller, U.. (2013) Evaluation of an algorithm for intensive subcutaneous insulin therapy in noncritically ill hospitalised patients with hyperglycaemia in a randomised controlled trial. Swiss Medical Weekly, 143. w13808.

2011

Albrecht, D. and Puder, J. and Keller, U. and Zulewski, H.. (2011) Potential of education-based insulin therapy for achievement of good metabolic control : a real-life experience. Diabetic medicine, Vol. 28, H. 5. pp. 539-542.

2010

Drescher, T. and Singler, K. and Ulrich, A. and Koller, M. and Keller, U. and Christ-Crain, M. and Kressig, R. W.. (2010) Comparison of two malnutrition risk screening methods (MNA and NRS 2002) and their association with markers of protein malnutrition in geriatric hospitalized patients. European journal of clinical nutrition : EJCN, Vol. 64, H. 8. pp. 887-893.

Fischer, M. and Timper, K. and Radimerski, T. and Dembinski, K. and Frey, D. M. and Zulewski, H. and Keller, U. and Müller, B. and Christ-Crain, M. and Grisouard, J.. (2010) Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots. Diabetes, Obesity and Metabolism, 12 (4). pp. 356-359.

2009

Philippe, J. and Braendle, M. and Carrel, J. and Diem, P. and Keller, U. and Kuntschen, F. and Ruiz, J. and Stahl, M. and Weissenberger, B. and Spinas, G. A.. (2009) Massnahmen zur Blutzuckerkontrolle bei Patienten mit Typ-2-Diabetes-mellitus : Consensus statement der Schweizerischen Gesellschaft für Endokrinologie und Diabetologie (SGED). Schweizerisches Medizin-Forum, Vol. 9, H. 3. pp. 50-55.

Bendik, C. Falconnier and Keller, U. and Moriconi, N. and Gessler, A. and Schindler, Ch and Zulewski, H. and Ruiz, J. and Puder, J. J.. (2009) Training in flexible intensive insulin therapy improves quality of life, decreases the risk of hypoglycaemia and ameliorates poor metabolic control in patients with type 1 diabetes. Diabetes research and clinical practice : affiliated with the International Diabetes Federation and published in collaboration with the Western Pacific Region of IDF, Vol. 83, H. 3. pp. 327-333.

2008

Stettler, C. and Stahl, M. and Allemann, S. and Diem, P. and Schmidlin, K. and Zwahlen, M. and Riesen, W. and Keller, U. and Christ, E.. (2008) Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care, Vol. 31. pp. 1534-1535.

Thomann, R. and Rossinelli, N. and Keller, U. and Tirri, B. F. and De Geyter, C. and Ruiz, J. and Kränzlin, M. and Puder, J. J.. (2008) Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome. Gynecological endocrinology, Vol. 24. pp. 199-206.

Linscheid, P. and Christ-Crain, M. and Stoeckli, R. and Reusch, C. E. and Lutz, T. A. and Müller, B. and Keller, U.. (2008) Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss. Diabetes, Obesity and Metabolism, 10 (12). pp. 1266-1270.

Hoch, M. and Eberle, A. N. and Peterli, R. and Peters, T. and Seboek, D. and Keller, U. and Muller, B. and Linscheid, P.. (2008) LPS induces interleukin-6 and interleukin-8 but not tumor necrosis factor-alpha in human adipocytes. Cytokine, 41 (1). pp. 29-37.

Leuenberger, S. and Gugleta, K. and Kochkorov, A. and Reinhard, G. and Kräuchi, K. and Keller, U. and Flammer, J. and Orgül, S.. (2008) Resting energy expenditure in vasospastic subjects and its potential relevance in glaucoma. Klinische Monatsblätter für Augenheilkunde, Vol. 225, H. 5. pp. 361-365.

2007

Seboek, D. and Eberhardt, M. and Barbero, A. and Linscheid, P. and Timper, K. and Martin, I. and Keller, U. and Muller, B. and Zulewski, H.. (2007) Bone marrow derived mesenchymal stem cells isolated from patients with diabetes mellitus type 1 are able to induce a pancreatic endocrine genes in vitro. Journal of stem cells & regenerative medicine, Vol. 2, H. 1. pp. 102-103.

Stoeckli, R. and Keller, U.. (2007) Low fat und Light-Produkte - Schnee von gestern? Therapeutische Umschau, Bd. 64, H. 3. pp. 147-152.

2006

Christ-Crain, M. and Stoeckli, R. and Ernst, A. and Morgenthaler, N. G. and Bilz, S. and Korbonits, M. and Struck, J. and Bergmann, A. and Muller, B. and Keller, U.. (2006) Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients. Journal of Clinical Endocrinology and Metabolism, 91 (9). pp. 3544-3547.

Bauer, C. and Fischer, A. and Keller, U.. (2006) Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder. Diabetes, obesity and metabolism, Vol. 8, H. 3. pp. 289-295.

Keller, U.. (2006) From obesity to diabetes. International journal for vitamin and nutrition research, Vol. 76, no. 4. pp. 172-177.

Puder, J. J. and Blum, C. A. and Mueller, B. and De Geyter, Ch and Dye, L. and Keller, U.. (2006) Menstrual cycle symptoms are associated with changes in low-grade inflammation. European Journal of Clinical Investigation, Vol. 36, H. 1. pp. 1-7.

Puder, J. J. and Varga, S. and Nusbaumer, C. P. and Zulewski, H. and Bilz, S. and Muller, B. and Keller, U.. (2006) Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia. European Journal of Clinical Investigation, 36 (12). pp. 883-889.

2005

Puder, J. J. and Atar, M. and Muller, B. and Pavan, M. and Keller, U.. (2005) Using insulin pen needles up to five times does not affect needle tip shape nor increase pain intensity. Diabetes Research and Clinical Practice, 67 (2). pp. 119-123.

Puder, J. J. and Lachelt, S. and Endrass, J. and Muller, B. and Keller, U.. (2005) What are disease perceptions and subjective treatment goals of insulin treated diabetic patients? Swiss Medical Weekly, 135 (25-26). pp. 365-371.

2004

von Mach, M. -A. and Stoeckli, R. and Bilz, S. and Kraenzlin, M. and Langer, I. and Keller, U.. (2004) Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism, Vol. 53, H. 7. pp. 918-921.

Christ-Crain, M. and Meier, C. and Puder, J. J. and Staub, J. J. and Huber, P. R. and Keller, U. and Müller, B.. (2004) Changes in liver function correlate with the improvement of lipid profile after restoration of euthyroidism in patients with subclinical hypothyroidism. EXCLI Journal, 3. pp. 1-9.

Rossi, L. and Parvin, S. and Hassan, Z. and Hildebrand, P. and Keller, U. and Ali, L. and Beglinger, C. and Azad Khan, A. K. and Whitcomb, David C. and Gyr, N.. (2004) Diabetes mellitus in Tropical Chronic Pancreatitis Is Not Just a Secondary Type of Diabetes. Pancreatology, 4 (5). pp. 461-467.

Stoeckli, R. and Keller, U.. (2004) Nutritional fats and the risk of type 2 diabetes and cancer. Physiology & behavior, Vol. 83, H. 4. pp. 611-615.

Hofbauer, K. G. and Keller, U. and Boss, O.. (2004) Perspectives and outlook. In: Pharmacotherapy of obesity. Boca Raton, FL, USA, pp. 467-471.

Pirovino, S. and Zehnder-Gerber, B. and Christ-Crain, M. and Keller, U. and Muller, B.. (2004) Spontanhypoglykämie bei Meningitis. Schweizerische Rundschau für Medizin PRAXIS, Vol. 93, H. 11. pp. 428-430.

2003

Keller, U. and Szinnai, G. and Bilz, S. and Berneis, K.. (2003) Effects of changes in hydration on protein, glucose and lipid metabolism in man : impact on health. European journal of clinical nutrition, Vol. 57, Suppl. 2. pp. 1-6.

Stoeckli, R. and Keller, U.. (2003) Wirksamkeit therapeutischer Interventionen bei Adipositas. Schweizerische Rundschau für Medizin PRAXIS, Vol. 92, H. 47. pp. 1-6.

2002

Meier, C. and Christ-Crain, M. and Keller, U. and Staub, J. J.. (2002) Psychische Veränderungen bei Hypo- und Hyperthyreosen. Deutsche medizinische Wochenschrift, Jg. 127, H. 21. pp. 1145-1150.

Stoeckli, R. and Keller, U.. (2002) Von der Adipositas zum Diabetes. Therapeutische Umschau, Bd. 59, H. 8. pp. 388-392.

2001

von Mach, M. A. and Keller, U.. (2001) Komorbiditäten und Beschwerden bei morbider Adipositas. Schweizerische Rundschau für Medizin PRAXIS, Vol. 90, H. 37. pp. 1569-1574.

2000

Berneis, K. and Keller, U.. (2000) Bioelectrical impedance analysis during acute changes of extracellular osmolality in man. Clinical nutrition, Vol. 19, H. 5. pp. 361-366.

Simon-Vermot, I. and Keller, U.. (2000) Folgen und Komplikationen der Adipositas. Therapeutische Umschau, Bd. 57, H. 8. pp. 493-497.

Berneis, K. and Battegay, M. and Bassetti, S. and Nuesch, R. and Leisibach, A. and Bilz, S. and Keller, U.. (2000) Nutritional supplements combined with dietary counselling diminish whole body protein catabolism in HIV-infected patients. European Journal of Clinical Investigation, Vol. 30, H. 1. pp. 1-7.

1999

Krauchi, K. and Keller, U. and Leonhardt, G. and Brunner, D. P. and van der Velde, P. and Haug, H. J. and Wirz-Justice, A.. (1999) Accelerated post-glucose glycaemia and altered alliesthesia-test in Seasonal Affective Disorder. Journal of affective disorders, Vol. 53, H. 1. pp. 23-26.

Heim, S. C. and De Geyter, C. and Siegrist, W. and Bilz, S. and Keller, U.. (1999) Das Syndrom der Polycystischen Ovarien (PCOS) - nur für Kinderwunsch relevant? Therapeutische Umschau, Bd. 56, H. 5. pp. 271-275.

Keller, U.. (1999) Der diabetische Fuss: Blick in die Zukunft. Schweizerische Rundschau für Medizin PRAXIS, Vol. 88, H. 27-28. pp. 1166-1169.

Berneis, K. and Oehri, M. and Kraenzlin, M. and Keller, U.. (1999) Effects of IGF-I combined with GH on glucocorticoid-induced changes of bone and connective tissue turnover in man. Journal of endocrinology, Vol. 162, H. 2. pp. 259-264.

Berneis, K. and Ninnis, R. and Haussinger, D. and Keller, U.. (1999) Effects of hyper- and hypoosmolality on whole body protein and glucose kinetics in humans. American journal of physiology : AJP, Vol. 276, H. 1, Pt. 1 , E188-E195.

Bilz, S. and Ninnis, R. and Keller, U.. (1999) Effects of hypoosmolality on whole-body lipolysis in man. Metabolism, Vol. 48, H. 4. pp. 472-476.

Heilmbauer, I. and Keller, U.. (1999) Eruptive Xanthome. Schweizerische Rundschau für Medizin PRAXIS, Vol. 88, H. 33. pp. 1327-1329.

Senn, B. and Orgul, S. and Keller, U. and Dickermann, D. and Dubler, B. and Vavrecka, J. and Gasser, P. and Kaiser, H. J. and Flammer, J.. (1999) Retrobulbar and peripheral capillary blood flow in hypercholesterolemic subjects. American journal of ophthalmology, Vol. 128, H. 3. pp. 310-316.

1998

Shalev, A. and Ninnis, R. and Keller, U.. (1998) Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy men. Hormone Research, 49 (5). pp. 221-225.

Nordmann, A. and Martina, B. and Keller, U. and Battegay, E.. (1998) Lipidsenkung: neue pathophysiologische Aspekte und klinische Implikationen. Schweizerische medizinische Wochenschrift, Jg. 128, Nr. 17. pp. 665-670.

Zulewski, H. and Ninnis, R. and Miserez, A. R. and Baumstark, M. W. and Keller, U.. (1998) VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. Journal of Lipid Research, 39, (2). pp. 380-387.

1997

Shalev, A. and Vosmeer, S. and Keller, U.. (1997) Absence of short-term effects of glucagon-like peptide-1 and of hyperglycemia on plasma leptin levels in man. Metabolism, Vol. 46, H. 7. pp. 723-725.

Hausmann, O. N. and Kirsch, E. and Lyrer, A. and Keller, U. and Steck, A. J.. (1997) Bilaterale Glomustumoren mit Blutdruckregulationsstörung durch Barorezeptordysfunktion. Deutsche medizinische Wochenschrift, Jg. 122, H. 9. pp. 253-258.

Jeck, T. and Riesen, W. F. and Keller, U.. (1997) Comparison of bezafibrate and simvastatin in the treatment of dyslipidaemia in patients with NIDDM. Diabetic medicine, Vol. 14, H. 7. pp. 564-570.

Berneis, K. and Ninnis, R. and Keller, U.. (1997) Ethanol exerts acute protein-sparing effects during postabsorptive but not during anabolic conditions in man. Metabolism, Vol. 46, H. 7. pp. 750-755.

Meier, C. and Ladewig, A. and Keller, U. and Berger, W.. (1997) Klinische Bedeutung der C-Peptid-Bestimmung. Schweizerische Rundschau für Medizin PRAXIS, Vol. 86, H. 34. pp. 1289-1295.

Battegay, E. and Gasche, A. and Zimmerli, L. and Martina, B. and Gyr, N. and Keller, U.. (1997) Risk factor control and perceptions of risk factors in patients with coronary heart disease. Blood pressure. Supplement, Vol. 1. pp. 1-7.

Shalev, A. and Keller, U.. (1997) Short-term effects of glucagon-like peptide 1 (7-36 amide) on leucine kinetics in healthy volunteers. Clinical nutrition, Vol. 16, H. 2. pp. 101-102.

1996

Fried, R. and Beckmann, N. and Keller, U. and Ninnis, R. and Stalder, G. and Seelig, J.. (1996) Early glycogenolysis and late glycogenesis in human liver after intravenous administration of galactose. American journal of physiology. Gastrointestinal and liver physiology, Vol. 270, H. 1 , G14-G19.

Berneis, K. and Vosmeer, S. and Keller, U.. (1996) Effects of glucocorticoids and of growth hormone on serum leptin concentrations in man. European journal of endocrinology, Vol. 135, H. 6. pp. 663-665.

Oehri, M. and Ninnis, R. and Girard, J. and Frey, F. J. and Keller, U.. (1996) Effects of growth hormone and IGF-I on glucocorticoid-induced protein catabolism in humans. American journal of physiology : AJP, Vol. 270, H. 4, Pt. 1 , E552-E558.

Jeck, T. and Keller, U.. (1996) Incidental adrenal mass hampers the diagnosis of an extra-adrenal phaeochromocytoma. Hormone research, Vol. 46, H. 6. pp. 282-283.

Keller, U.. (1996) Malnutrition im Spital. Schweizerische medizinische Wochenschrift, Jg. 126 , Suppl. 79. pp. 1-7.

Berneis, K. and Keller, U.. (1996) Metabolic actions of growth hormone : direct and indirect. Baillière's clinical endocrinology and metabolism, Vol. 10, H. 3. pp. 337-352.

Martina, B. and Weinbacher, M. and Kiener, S. and Keller, U. and Battegay, E.. (1996) Reproduzierbarkeit von Nüchtern-Serumcholesterin und Triglyzeriden bei ambulanten Patienten mit gemischter Hyperlipidämie. Schweizerische medizinische Wochenschrift, Jg. 126, Nr. 50. pp. 2175-2180.

1995

Miserez, A. R. and Keller, U.. (1995) Differences in the phenotypic characteristics of subjects with familial defective apolipoprotein B-100 and familial hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology, Vol. 15, H. 10. pp. 1719-1729.

Renggli, K. and Keller, U.. (1995) Ernähren sich Typ-I-Diabetiker entsprechend den Empfehlungen? Schweizerische Rundschau für Medizin PRAXIS, Vol. 84, H. 9. pp. 255-258.

Keller, U.. (1995) Glucose-Ersatzstoffe in der parenteralen Ernährung. Deutsche medizinische Wochenschrift, Jg. 120, H. 11. pp. 1-6.

Keller, U.. (1995) Hypercholesterinämie bei Kindern und Jugendlichen: Ist ein Screening sinnvoll? Schweizerische medizinische Wochenschrift, Jg. 125 , Nr. 7. pp. 255-263.

Winiger, G. and Keller, U. and Laager, R. and Girard, J. and Berger, W.. (1995) Protein content of the evening meal and nocturnal plasma glucose regulation in type-I diabetic subjects. Hormone research, Vol. 44, H. 3. pp. 101-104.

Keller, U.. (1995) Woran scheitert die Ernährungstherapie bei nicht-insulinabhängigem Diabetes? Welche Massnahmen bringen Erfolg? Therapeutische Umschau, Bd. 52, H. 8. pp. 501-508.

1994

Zulewski, H. and Keller, U.. (1994) Der Fall aus der Praxis (284). Insulinom im Pankreaskopf. Schweizerische Rundschau für Medizin PRAXIS, Vol. 83, H. 4. pp. 111-113.

Miserez, A. R. and Laager, R. and Chiodetti, N. and Keller, U.. (1994) High prevalence of familial defective apolipoprotein B-100 in Switzerland. Journal of Lipid Research, 35 (4). pp. 574-583.

Miserez, A. R. and Rossi, F. A. and Keller, U.. (1994) Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects. European journal of clinical pharmacology, Vol. 46, H. 2. pp. 107-114.

Miserez, A. R. and Keller, U.. (1994) Prävention der koronaren Herzkrankheit bei familiären Hypercholesterinämien. Therapeutische Umschau, Bd. 51, H. 10. pp. 671-676.

Kogon, M. M. and Kraeuchi, K. and Van der Velde, P. and Van der Werf, H. and Keller, U.. (1994) Psychological and metabolic effects of dietary carbohydrates and dexfenfluramine during a low-energy diet in obese women. American journal of clinical nutrition, Vol. 60, H. 4. pp. 488-493.

Buechi, E. and Diem, P. and Golay, A. and Keller, U. and Lehmann, T. and Prodolliet, B. and Reinli, K. and Salomon, F.. (1994) Stellungnahme zur Diabetes-Ernährung 1994. Schweizerische medizinische Wochenschrift, Jg. 124 , Suppl. 60. pp. 30-42.

1993

Keller, U.. (1993) Cholesterin in Nahrung und Serum. Deutsche medizinische Wochenschrift, Vol. 118, H. 1-2. pp. 1-4.

Laager, R. and Ninnis, R. and Keller, U.. (1993) Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. Journal of Clinical Investigation, Vol. 92, H. 4. pp. 1903-1909.

Bloesch, D. and Keller, U. and Spinas, G. A. and Kury, D. and Girard, J. and Stauffacher, W.. (1993) Effects of endotoxin on leucine and glucose kinetics in man : contribution of prostaglandin E2 assessed by a cyclooxygenase inhibitor. Journal of clinical endocrinology and metabolism, Vol. 77, H. 5. pp. 1156-1163.

Laager, R. and Keller, U.. (1993) Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects. Diabetologia, Vol. 36, H. 10. pp. 966-971.

Martina, B. and Keller, U.. (1993) Intraindividuelle Schwankungen der Triglycerid- und Gesamtcholesterinkonzentrationen im Serum bei gemischter Hyperlipidämie. Deutsche medizinische Wochenschrift, Vol. 118, H. 12. pp. 405-409.

Beckmann, N. and Fried, R. and Turkalj, I. and Seelig, J. and Keller, U. and Stalder, G.. (1993) Noninvasive observation of hepatic glycogen formation in man by 13C MRS after oral and intravenous glucose administration. Magnetic Resonance in Medicine, 29 (5). pp. 583-590.

Keller, U.. (1993) Pathophysiology of cancer cachexia. Supportive care in cancer, Vol. 1, H. 6. pp. 290-294.

Miserez, A. R. and Schuster, H. and Chiodetti, N. and Keller, U.. (1993) Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations. American journal of human genetics, Vol. 52, H. 4. pp. 808-826.

1992

Straumann, E. and Keller, U. and Kury, D. and Bloesch, D. and Thelin, A. and Arnaud, M. J. and Stauffacher, W.. (1992) Effect of acute acidosis and alkalosis on leucine kinetics in man. Clinical physiology, Vol. 12, H. 1. pp. 1-7.

Turkalj, I. and Keller, U. and Ninnis, R. and Vosmeer, S. and Stauffacher, W.. (1992) Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man. Journal of clinical endocrinology and metabolism, Vol. 75, H. 5. pp. 1186-1191.

Beckmann, N. and Brocard, J. J. and Keller, U. and Seelig, J.. (1992) Relationship between the degree of unsaturation of dietary fatty acids and adipose tissue fatty acids assessed by natural-abundance 13C magnetic resonance spectroscopy in man. Magnetic Resonance in Medicine, 27 (1). pp. 97-106.

Spinas, G. A. and Keller, U. and Brockhaus, M.. (1992) Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. Journal of Clinical Investigation, Vol. 90, H. 2. pp. 533-536.

1991

Beckmann, N. and Turkalj, I. and Seelig, J. and Keller, U.. (1991) 13C NMR for the assessment of human brain glucose metabolism in vivo. Biochemistry, Vol. 30, H. 26. pp. 6362-6366.

Bodenmann, A. and Ackermann-Liebrich, U. and Keller, U.. (1991) Fleischkonsum und Serum-Cholesterinkonzentration. Deutsche medizinische Wochenschrift, Jg. 116, H. 28-29. pp. 1089-1094.

Keller, U. and Miles, J. M.. (1991) Growth hormone and lipids. Hormone research, Vol. 36, Suppl. 1. pp. 1-6.

Keller, U.. (1991) Hormonsubstitution in der Menopause : Einfluss auf Lipide und kardiovaskuläres Risiko. Schweizerische Rundschau für Medizin PRAXIS, Vol. 80, H. 16. pp. 413-417.

Keller, U.. (1991) Partielle Fructose-Intoleranz oder Fructose-Malabsorption? Deutsche medizinische Wochenschrift, Jg. 116, H. 17. pp. 1-6.

Spinas, G. A. and Bloesch, D. and Keller, U. and Zimmerli, W. and Cammisuli, S.. (1991) Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia. Journal of infectious diseases, Vol. 163, no. 1. pp. 1-8.

Kury, D. and Keller, U.. (1991) Trimethylsilyl-O-methyloxime derivatives for the measurement of [6,6-2H2]-D-glucose-enriched plasma samples by gas chromatography-mass spectrometry. Journal of chromatography, Vol. 572, H. 1-2. pp. 302-306.

Keller, U. and Wackernagel, C. and Messer, C. and Riesen, W.. (1991) Vergleich einer kalorien-definierten Diät mit der konventionellen Austauschdiät bei Diabetes mellitus Typ 2. Schweizerische medizinische Wochenschrift, Jg. 121, H. 27-28. pp. 1014-1019.

Brocard, J. J. and Keller, U. and Oberhansli, A. and Riesen, W. F.. (1991) Wirkungen und Nebenwirkungen einer einjährigen Behandlung der primären Hypercholesterinämie mit Simvastatin. Schweizerische medizinische Wochenschrift, Jg. 121, H. 26. pp. 977-983.

1990

Ryff, A. and Keller, U.. (1990) Der Fall aus der Praxis (167). Verminderte Glukosetoleranz mit reaktiver postprandialer Hypoglykamie bei Adipositas. Schweizerische Rundschau für Medizin PRAXIS, Vol. 79, H. 11. pp. 341-343.

Waldmann, C. and Keller, U.. (1990) Der Fall aus der Praxis (175): Bartter-syndrom. Schweizerische Rundschau für Medizin PRAXIS, Vol. 79, H. 17. pp. 540-541.

Keller, U. and Golay, A. and Pometta, D.. (1990) Dyslipidamie bei Diabetes mellitus : Bedeutung, Diagnostik und Behandlung. Schweizerische Rundschau für Medizin PRAXIS, Vol. 79, H. 41. pp. 1199-1204.

Spinas, G. A. and Bloesch, D. and Kaufmann, M. T. and Keller, U. and Dayer, J. M.. (1990) Induction of plasma inhibitors of interleukin 1 and TNF-alpha activity by endotoxin administration to normal humans. American journal of physiology : AJP, Vol. 259, H. 5 Pt. 2 , R993-R997.

Keller, U.. (1990) Lipidsenkende Therapie zur Pravention der koronaren Herzkrankheit. Schweizerische Rundschau für Medizin PRAXIS, Vol. 79, H. 39. pp. 1120-1124.

Keller, U.. (1990) Medikamente gegen Übergewicht. Therapeutische Umschau, Bd. 47, H. 8. pp. 658-663.

Keller, U. and Kraenzlin, M. E. and Gratwohl, A. and Thelin, A. and Straumann, E. and Arnaud, M. J. and Speck, B. and Stauffacher, W.. (1990) Protein metabolism assessed by 1-13C leucine infusions in patients undergoing bone marrow transplantation. Journal of parenteral and enteral nutrition, Vol. 14, H. 5. pp. 480-484.

Keller, U.. (1990) Serumcholesterin von Schweizer Wehrmännern und Erhebung über die Ernährung im Militärdienst. Schweizerische Rundschau für Medizin Praxis = Revue suisse de médecine PRAXIS, Vol. 79, H. 38. pp. 1079-1084.

1989

Stohler, R. and Keller, U. and Riesen, W. F.. (1989) Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia. European journal of clinical pharmacology, Vol. 37, H. 2. pp. 1-7.

Kraenzlin, M. E. and Keller, U. and Keller, A. and Thelin, A. and Arnaud, M. J. and Stauffacher, W.. (1989) Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms. Journal of Clinical Investigation, Vol. 84, H. 2. pp. 388-393.

Keller, U. and Lustenberger, M. and Mueller-Brand, J. and Gerber, P. P. and Stauffacher, W.. (1989) Human ketone body production and utilization studied using tracer techniques : regulation by free fatty acids, insulin, catecholamines, and thyroid hormones. Diabetes metabolism reviews, Vol. 5, H. 3. pp. 285-298.

Berger, W. and Keller, U. and Honegger, B. and Jaeggi, E.. (1989) Warning symptoms of hypoglycaemia during treatment with human and porcine insulin in diabetes mellitus. Lancet, Vol. 334, no. 8646. pp. 1041-1044.

Keller, U.. (1989) Zuckeraustauschstoffe Fruktose und Sorbit : ein unnötiges Risiko in der parenteralen Ernährung. Schweizerische medizinische Wochenschrift, Jg. 119, Nr. 4. pp. 101-106.

1988

Widmer, A. and Keller, U. and Pasquel, M. and Berger, W.. (1988) Alterations in insulin clearance and hepatic blood flow during the night do not contribute to the "dawn phenomenon" in type 1 diabetes. Hormone research, Vol. 29, H. 5-6. pp. 1-6.

Beglinger, C. and Koehler, E. and Born, W. and Fischer, J. A. and Keller, U. and Hanssen, L. E. and Gyr, K.. (1988) Effect of calcitonin and calcitonin gene-related peptide on pancreatic functions in man. Gut, Vol. 29, H. 2. pp. 243-248.

Keller, U. and Lustenberger, M. and Stauffacher, W.. (1988) Effect of insulin on ketone body clearance studied by a ketone body "clamp" technique in normal man. Diabetologia, Vol. 31, no. 1. pp. 24-29.

Hood, V. L. and Schubert, C. and Keller, U. and Muller, S.. (1988) Effect of systemic pH on pHi and lactic acid generation in exhaustive forearm exercise. American journal of physiology : AJP, Vol. 255, H. 3, Pt. 2 , F479-F485.

Keller, U. and Gerber, P. P. and Stauffacher, W.. (1988) Fatty acid-independent inhibition of hepatic ketone body production by insulin in humans. American journal of physiology : AJP, Vol. 254, H. 6. Pt. 1 , E694-E699.

Straumann, E. and Keller, U. and Kraenzlin, M. and Girard, J. and Thelin, A. and Arnaud, M. and Perruchoud, A. and Stauffacher, W.. (1988) Interaction of cortisol and epinephrine in the regulation of leucine kinetics in man. Experientia, Vol. 44, Nr. 2. pp. 176-178.

1987

Stark, B. and Keller, U.. (1987) Alpha 1-adrenergic stimulation of ketogenesis and fatty acid oxidation is associated with inhibition of lipogenesis in rat hepatocytes. Experientia, Vol. 43, Nr. 10. pp. 1104-1106.

1985

Keller, U. and Beglinger, C. and Berger, W.. (1985) Identification of subjects with a high risk of developing type 1 (insulin-dependent) diabetes : summary of a workshop held on 25 May 1984 at the Children's Hospital, Basel, Switzerland. Diabetologia, Vol. 28, no. 1. pp. 57-58.

Keller, U. and Oberhansli, R. and Huber, P. and Widmer, L. K. and Aue, W. P. and Hassink, R. I. and Muller, S. and Seelig, J.. (1985) Phosphocreatine content and intracellular pH of calf muscle measured by phosphorus NMR spectroscopy in occlusive arterial disease of the legs. European Journal of Clinical Investigation, Vol. 15, H. 6. pp. 382-388.

1984

Cross, T. A. and Pahl, C. and Oberhansli, R. and Aue, W. P. and Keller, U. and Seelig, J.. (1984) Ketogenesis in the living rat followed by 13C NMR spectroscopy. Biochemistry, Vol. 23, H. 26. pp. 6398-6402.

1981

Keller, U. and Schade, D. S.. (1981) Current status of portable insulin infusion devices : satellite workshop on portable insulin infusion devices (Preceding the XVth annual meeting of the European Society for Clinical Investigation) 18-19 March 1981, Basel, Switzerland. Diabetologia, Vol. 21, no. 4. pp. 425-426.

1979

Berger, W. and Keller, U. and Vorster, D.. (1979) Die Letalität des Coma diabeticum am Kantonsspital Basel in den zwei aufeinanderfolgenden Beobachtungsperioden 1968-1973 und 1973-1978 mit konventioneller Insulintherapie und Behandlung mit niederen Insulindosen. Schweizerische medizinische Wochenschrift, Jg. 109, Nr. 46. pp. 1820-1824.